This multicenter, retrospective cohort study aimed to develop and validate an explainable prediction model for prognosis after gastrectomy in patients with gastric cancer.
This multicenter, retrospective cohort study aimed to develop and validate an explainable prediction model for prognosis after gastrectomy in patients with gastric cancer. The study included patients who underwent radical gastrectomy for primary gastric or gastroesophageal junction cancer across multiple institutions in China. The primary objective was to create a machine learning-based model to predict postoperative outcomes following gastrectomy, using readily available clinical and pathological parameters. The main outcome of interest was early recurrence within 2 years after surgery, which significantly impacts overall prognosis. The study employed various machine learning algorithms to develop prediction models, which were then compared and validated. Model performance was assessed through measures such as area under the receiver operating characteristic curve (AUC), calibration, and Brier score. The SHapley Additive exPlanations (SHAP) method was used to interpret the model and rank feature importance. This research aims to provide clinicians with a tool for identifying patients at higher risk of poor postoperative outcomes who may benefit from more intensive post-operative monitoring and early intervention strategies, potentially improving prognosis for gastric cancer patients.
Study Type
OBSERVATIONAL
Enrollment
18,000
Chang-ming Huang
Fuzhou, Fujian, China
Survival
Assessment of overall survival outcomes in gastric cancer patients after gastrectomy.
Time frame: Up to 5 years after surgery
Early Recurrence
Incidence of cancer recurrence within 2 years after gastrectomy.
Time frame: Within 2 years after surgery
Late Recurrence
Incidence of cancer recurrence occurring more than 2 years after gastrectomy.
Time frame: From 2 years up to 5 years after surgery
Postoperative Complications
Incidence and severity of complications following gastrectomy.
Time frame: Within 30 days after surgery
Neoadjuvant Treatment Efficacy
Assessment of tumor response to neoadjuvant therapy before gastrectomy.
Time frame: From initiation of neoadjuvant therapy to surgery (typically 2-3 months)
5-Year Survival Rate
Percentage of patients alive 5 years after gastrectomy.
Time frame: 5 years after surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.